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Abstract.  The Engelbreth-Holm-Swarm mouse tumor 
has been found to produce at least two molecular 
species of heparan sulfate proteoglycan, a  low density 
one (LD) and a high density one, which differ not 
only in core proteins but also in glycosaminoglycan 
structures (Kato, M., Y.  Koike, Y.  Ito, S.  Suzuki, and 
K. Kimata.  1987.  J.  Biol.  Chem.  262:7180-7188).  With 
aim at investigating their distribution and possible 
functions in tissues, monoclonal antibodies were pro- 
duced. Hybridomas obtained by fusion of NS-1  mouse 
myeloma cells with spleen cells from the rat im- 
munized with a mixture of these proteoglycans were 
selected by their ability to react with the antigen. Two 
of them secreted monoclonal antibodies (IgG2a), 
designated HK-84 and HK-102, that recognize spe- 
cifically the core protein moiety of LD. 
Immunofluorescent staining of various tissues (skele- 
tal muscle, cardiac muscle, lung, brain, and kidney) 
with these monoclonal antibodies has demonstrated 
that the antigen molecules were present in all base- 
ment membranes of these tissues.  SDS-PAGE of hep- 
aritinase-treated proteoglycan fractions prepared from 
these tissues and subsequent immunoblotting using 
these monoclonal antibodies have confirmed that the 
antigen molecule was LD, and further suggested that 
there was a  tissue-specific variation in the core molec- 
ular size. 
Based on these results, we propose that LD may be 
an essential component in all basement membranes. 
H 
EPARAN sulfate proteoglycans have been classified 
into at least two families, cell surface type and base- 
ment membrane type, which are different not only 
in their distributions but also in their functions (Stow et al., 
1985a,  b; Jalkanen et al.,  1985). 
Antibodies to basement membrane heparan sulfate pro- 
teoglycan were first raised against the one from the Engel- 
breth-Holm-Swarm (EHS) ~  mouse tumor, designated BM-1 
(Hassell  et  al.,  1980).  Immunohistological studies  using 
these antibodies have shown that most if not all basement 
membranes contain determinants of the antibodies (Hassell 
et al.,  1980;  Kimata et al.,  1985;  Thesleff et al.,  1981). 
However,  heparan sulfate proteoglycan in the EHS tumor 
was then found to be separated into two forms, low density 
form (LD)  and high density form (HD)  (Dziadek et al., 
1985;  Fujiwara et al.,  1984;  Hassell et al.,  1985),  and we 
have recently demonstrated that LD and most of HD are 
different molecules, not only in their core molecular species 
but also in their glycosaminoglycan  chain structures (Kato et 
1. Abbreviations used in this paper:  EHS,  Engelbreth-Holm-Swarm;  HD, 
high density species of heparan sulfate proteoglycan;  LD, low density spe- 
cies of heparan sulfate proteoglycan. 
al.,  1987).  LD is a large proteoglycan containing heparan 
sulfate chains  attached to  a  single core  molecule (M,  = 
450,000),  whereas HD is a mixture of small proteoglycans 
with  four  different  size  core  molecules  (Mr  =  34,000, 
29,000, 27,000, and 21,000), most if  not all of  which bear both 
heparan sulfate and chondroitin sulfate. 
Therefore, the wide reactivity of anti-BM-1 antibody with 
basement membranes of various tissues might be explained 
by assuming that anti-BM-1 antibody can recognize various 
molecules immunologically related to both LD and HD. An- 
tibodies that were subsequently raised against purified LD or 
HD, however, crossreacted each other (Dziadek et al., 1985; 
Hassell et al., 1985) and LD and HD appeared to have com- 
mon antigenic determinants although shared determinants 
differed in an affinity to the antibodies between LD and HD 
(Dziadek et al., 1985). This motivated us to produce a mAb 
specific for either LD or HD, to use as a reliable tool to inves- 
tigate their tissue distributions and functions. 
In this paper we first describe the establishment of two 
mAbs against LD. By using them, we have examined the dis- 
tribution in various tissues and characterized the core mole- 
cules of LD isolated from those tissues. We show here that 
these mAbs stained all basement membranes in all tissues 
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ney) and detected core molecules identical in size to LD. 
Materials and Methods 
Materials 
DEAE-Sephacel, Sepharose CL-4B, and low molecular mass protein stan- 
dards  for  SDS-PAGE  were  purchased  from  Pharmacia,  Tokyo  Japan; 
phenylmethylsulfonyl fluoride,  DNase  I  (type  IV;  protease  free),  VS- 
protease (protease type XVII), BSA, and myosin were from Sigma Chemi- 
cal Co., St. Louis, MO; 3-[(3-cholamidopropyl)dimethylammonio]-l-pro- 
panesulfonate (CHAPS) was from Dojindo Laboratories, Kumamoto Japan; 
polystyrene 96-well plates were from Linbro, Flow Laboratories, Hamden, 
CT; peroxidase-conjugated  rabbit anti-rat Ig(G+M) immunoglobulins were 
from DAKOPATTS, Copenhagen, Denmark; peroxidase-conjugated  protein 
A was from E. Y. Laboratories, Inc., San Mateo, CA; FITC-conjugated rab- 
bit anti-rat Ig(G+M)  immunoglobulins were from Zymed Laboratories, 
Inc., San Francisco, CA; FITC-conjugated goat anti-rabbit IgG immuno- 
globulins were from Cappel Laboratories, Inc., Cochranville, PA; mAb typ- 
ing kit for rat immunoglobulins was from Miles Laboratories Inc., Naper- 
ville, IL. 
Laminin and type IV collagen were prepared from the EHS mouse tumor 
according  to  the  method  of Kleinman et  al.  (Kleinman et  al.,  1982). 
Anti-type IV collagen serum was obtained from a rabbit immunized with 
the mouse EHS tumor type IV collagen as described previously (Kimata et 
al., 1985).  As the serum had a slight cross-reactivity with laminin, the se- 
rum was passed through a laminin-conjugated Sepharose 4B column. The 
preparation thus obtained had no reactivity with other basement membrane 
components, laminin, heparan sulfate proteoglycan, and other types of col- 
lagen as tested by ELISA and immunoblotting (not shown). Affinity-purified 
anti-BM-1 polyclonal antibodies (Hassell et al., 1980) were a gift from Drs. 
J.  R.  Hassell, H.-J.  Barrach, and G. R.  Martin of the National Institutes 
of Health,  Bethesda,  MD.  Heparitinase  2 was a  generous gift  from  M. 
Mizutani of Seikagaku  Kogyo,  Co., Tokyo Japan. 
Preparation of  Heparan Sulfate Proteoglycans 
from the EHS Tumor 
The preparation was described previously (Hassell et al., 1985; Kato et al., 
1987).  Briefly,  freshly harvested tumor  tissue  was  extracted with 4  M 
guanidine-HCl, 50 mM Tris-HCl, pH 7.4,  1% CHAPS (wt/vol), protease 
inhibitors (1 mM phenylmethylsulfonyl  fluoride, 10 mM N-ethylmaleimide, 
10 mM EDTA), and the extract was fractionated by CsCI density gradient 
at starting density of P0 =  1.35 g/ml. The bottom fractions (p >  1.35 g/ml) 
were pooled and applied to DEAE-Sephacel column in 7 M urea, 50 mM 
Tris-HCl, pH 7.4, 0.5 % (vol/vol) Triton X-100, protease inhibitors. Bound 
materials were eluted with a linear gradient of 0-0.75 M NaCI  in the same 
solution. Hexuronate-positive fractions (eluted with 0.3-0.6 M NaCI) were 
pooled and subjected to Sepharose CL-4B column chromatography in 4 M 
guanidine-HCl, 50 mM Tris-HCl, pH 7.4,  1% CHAPS (wt/vol), protease 
inhibitors. The fractions (Kav=  0-0.5) were pooled and further fraction- 
ated into two forms, LD and HD,  by CsC1 density gradient (P0  =  1.50 
g/ml) in the same solution. 
Preparation of the lmmunogen for 
Monoclonal Antibodies 
An  aliquot  of the  heparan  sulfate  proteoglycan fraction  after  DEAE- 
Sephacel column chromatography (a mixture of LD and HD) was reduced 
with 10 mM dithiothreitol at 50°C for 2 h in 4 M guanidine-HCI, 100 mM 
Tris-HCl, pH 8.0. After addition of solid iodoacetamide to give a final con- 
centration of 30 mM, the sample was allowed to stand at room temperature 
for 3 h in the dark. The reduced heparan sulfate proteoglycan fraction thus 
obtained and the unreduced one were mixed and desalted by ethanol precipi- 
tation (Kimata et al.,  1974),  and the precipitate was dissolved in PBS. 
2. One unit of heparitinase was defined as the amount of the enzyme re- 
quired to release 1 lamol of unsaturated oligosaccharides/min. 
Immunization and Production of 
Monoclonal Antibodies 
A mixture of unreduced and reduced heparan sulfate proteoglycan fractions 
(each contained 200 I.tg heparan sulfate proteoglycan as protein) in 250 lal 
of PBS was mixed with the equal volume of Freund's complete adjuvant and 
intraperitoneally  injected into  a  5-wk-old Wister  rat.  The  rat  received 
booster injections with Freund's incomplete adjuvand at 2-wk intervals. 
1 wk after each injection, blood samples were taken to test reactivity with 
heparan sulfate proteoglycan by ELISA (see below). The rat with the fifth 
injection gave a high titer (>50,000)  and 3 d after the sixth injection, the 
spleen was harvested. 
For hybridoma production, a single cell suspension of rat spleen cells (1.5 
×  108 cells) was mixed with NS-1 mouse myeloma cells at a lymphocyte/ 
myeloma ratio of 10:1 and treated with polyethylene glycol 4,000.  The cells 
were plated in 96-well plates at a density of 1.5  x  105 cells/well in RPMI 
medium  containing  10%  (vol/vol)  FCS  and  hypoxantine-aminopterin- 
thymidine. Hybridoma supernatants were screened by ELISA (see below). 
Hybridomas that showed a positive reaction were cloned and then subcloned 
by limiting dilution. 
Screening and Characterization of  mAbs 
ELISA was done as described by Rennard et al. (Rennard et al., 1981) with 
a slight modification. Briefly, antigen solution containing 0.1 lag (as protein) 
of either beparan sulfate proteoglycan, or laminin, or type IV collagen, in 
100 ILl Voller's buffer was added to each well of a 96-well polystyrene plate 
and the plate was incubated overnight at 4°C. The solution was replaced 
with 100 lal PBS/I% (vol/vol)  BSA and incubated for 1 h at 37°C to block 
the nonspecific binding of the antibody solution, and the wells were rinsed 
with 200 lal PBS, 0.05%  (vol/vol) Tween 20 (PBS/Tween) three times. In 
some cases, each well was treated with 0.1 mU heparitinase in 100 p.l 100 
mM Tris-HCl, pH 7.2,  5 mM calcium acetate, protease inhibitors (Kato et 
al., 1985) for 1 h at 37°C before blocking. After the addition of 100 I11 hy- 
bridoma medium (pH was adjusted to 7.4 with Tris-HCl buffer), the plate 
was incubated for 2 h at room temperature. After rinsing the wells with 
PBS/Tween three times,  100 lal peroxidase-conjugated anti-rat Ig(G+M) 
serum (final dilution 1:500 in PBS/Tween) was added to each well and the 
plate was incubated for 1 h at room temperature. The wells were rinsed four 
times with 200 lal of PBS/Tween. Peroxidase binding was measured by de- 
veloping color using 0.01% (wt/vol) o-phenylenediamine containing 0.03% 
(vol/vol)  hydrogen  peroxide.  For  positive  control,  diluted  (1:1,000  in 
PBS/Tween) rat anti-heparan sulfate proteoglycan antiserum obtained from 
the immunized rat was used. Nonspecific color reaction was minimized un- 
der these conditions (not shown). 
SDS-PAGE and lmmunoblotting 
LD samples (1 lag as protein each) were treated with 1 mU heparitinase each 
for I h at 37°C (Kato et al., 1985). The digests were lyophilized, redissolved 
in  40  lal  of 2%  (wt/vol)  SDS,  2%  (wt/vol)  glycerol, 0.002%  (wt/vol) 
bromophenol blue with or without 5% (vol/vol) mercaptoethanol, and in- 
cubated at 37°C for 30 min. The samples were subjected to SDS-PAGE un- 
der the unreduced condition using a 5%  separation gel (Laemmli,  1970). 
After the electrophoresis, proteins were transferred to a nitrocellulose mem- 
brane according to the method of Towbin et al. (Towbin et al.,  1979). The 
membrane was soaked with 0.15 M NaCI/50 mM Tris-HCl, pH 7.4 (TBS), 
1% (wt/vol) BSA for 1 h at 37°C,  and incubated with hybridoma medium 
for 2 h at room temperature. After rinsing the membrane three times with 
TBS, 0.02 % (vol/vol) Tween 20 (TBS/Tween), the membrane was incubated 
with peroxidase-conjugated  anti-rat Ig(G+M) (fnal dilution, 1:500 in TBS/ 
Tween) for 1 h at room temperature. The membrane was rinsed with TBS/ 
Tween four times and the binding peroxidase was visualized by developing 
color using 0.05%  (wt/vol) 4-chloro-l-naphthol containing 0.03%  (vol/vol) 
hydrogen peroxide in TBS. For detection of proteins, the SDS-gel running 
at the same time was stained with Coomassie Blue R-250. 
Detection of V8 Protease  Fragments  of  LD with mAbs 
LD samples (4 lag as protein each) were incubated with V8 protease (pro- 
teoglycan/protease =  100:1 dry weight ratio) in 50 mM Tris-HCI, pH 7.4, 
for 5 h at 37°C.  The digests were subjected to SDS-PAGE using a 5-15% 
gradient gel, and followed by immunoblotting as described above. For de- 
tection of proteins, the SDS-gel running at the same time was stained with 
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b (94,000 Mr),  albumin (67,000 Mr), ovalbumin (43,000 Mr), carbonic an- 
hydrase (30,000 Mr),  trypsin inhibitor (20,000 Mr),  a-lactalbumin (14,000 
Mr) were used for determination of molecular masses of immunoreactive 
bands. 
Immunofluorescent  Staining 
Cryostat sections (6 p.m thick) of tissues from 4-wk-old C57 black mice 
were prepared without fixation. They were incubated with the hybridoma 
medium or diluted anti-mouse type IV collagen antibodies (1:30 in PBS), 
and processed for immunofluorescent staining as described previously (Ki- 
mata et al.,  1985).  For positive controls, EHS tumor tissue sections were 
stained as above. For negative controls, RPMI, 10% (vol/vol) FCS or diluted 
0:30 in PBS) nonimmunized rat serum were replaced with the hybridoma 
medium. 
lmmunodetection  of Core Molecules of 
Heparan Sulfate Proteoglycans Isolated from 
Various Tissues 
1 g  of various tissues from 4-wk-old C57  black  mice (skeletal  muscle, 
cardiac muscle, lung, whole brain [including cerebrum, mesencephalon, 
and cerebellum], and kidney), were homogenized with a glass homogenizer 
in 7.5  ml of 7  M  urea,  0.15  M  NaCI,  50  mM Tris-HCl, pH  7.4,  0.5% 
(vol/vol)  Triton X-100,  protease inhibitors,  and extracted twice  with the 
same solution for 12 h at 4°C. The extracts were applied to DEAE-Sephacel 
columns (1.5  x  3  cm),  and bound materials were eluted with two-fold 
column volume of 1 M NaCI in the same solution. After ethanol precipita- 
tion, samples were treated with 200 tag DNase I in 2 ml of 10 mM Tris-HCl, 
pH 7.0, 10 mM KCI, 3  mM MgC12, 2 mM phenylmethylsulfonyl fluoride 
at 37°C for 15 min. After ethanol precipitation to remove DNA fragments, 
samples (2 nmol hexuronate each) were digested with 10 mU of heparitinase 
for  1 h at 37°C, and subjected to SDS-PAGE using a  5-15%  gradient gel 
and subsequent immunoblotting as described above. For positive control, 
the EHS  tumor tissue (1  g) was extracted and processed the same way. 
Affinity-purified anti-BM-1 polyclonal antibodies (1:2,000 in TBS/Tween) 
were also used as a  probe  for basement membrane heparan sulfate pro- 
teoglycans, and detected with peroxidase-conjugated protein A (1:1,000 in 
TBS/Tween). Molecular masses of immunoreactive bands were determined 
as described above. 
Preparation of  Glomeruli and Analysis of the 
Heparan Sulfate Proteoglycans 
Glomeruli were isolated by the graded sieving technique (Kobayashi et al., 
1983).  Briefly,  40 kidneys from 20 of 4-wk-old C57 black mice were used 
as a starting material. The preparation contained at least 70% pure glomer- 
uli under the observation by phase contrast microscopy (not shown). 
Urea/Triton X-100 extract of the glomerulus preparation was applied to 
DEAE-Sephacel column (0.8  ×  1.5 cm) as described above. Bound mate- 
rials were eluted and used for SDS-PAGE and subsequent immunoblotting. 
Results 
Production and Characterization of  mAbs 
A rat was immunized with a mixture of LD and HD, half of 
which had been subjected to reduction of disulfide bonds 
with  dithiothreitol.  The antiserum  obtained  from  the  rat 
reacted with both LD and HD although the reactivity with 
HD was fairly low (Fig.  1 C).  Hybridization of the spleen 
cells and mouse myeloma was performed as described in 
Materials  and  Methods.  Hybridoma  supernatants  were 
tested for the reactivity by ELISA with the heparan sulfate 
proteoglycan preparation used as  immunogen.  23  hybrid- 
omas showed a positive reaction and cloned two times by 
limiting dilution. 
Two of the cloned hybridomas, designated HK-84 (IgG2a) 
and  HK-102  (IgG2a),  recognized  LD  and  heparitinase- 
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Figure 1. Specificities of HK- 
84  (A), HK-102 (B),  or rat 
anti-heparan  sulfate  proteo- 
glycan antiserum  (C).  Reac- 
tivities with LD (column 1), 
heparitinase-digested LD (col- 
umn 2), reduced LD (column 
3), HD (column 4), laminin 
(column 5), and type IV col- 
lagen (column 6) were exam- 
ined by ELISA. Note that both 
monoclonal antibodies had no 
reactivity  with  reduced  LD 
and  HD although polyclonal 
antibodies had reactivity with 
both.  Absorbance at 480 nm 
of a blank well was 0.02. 
treated LD (the core molecules of LD), but not reduced LD, 
HD,  laminin,  and type IV collagen (Fig.  1).  It should be 
noted here that both monoclonal antibodies did not show any 
reactivity with HD. Both monoclonal antibodies could only 
react  with  antigens  from  mice  as  far  as  we  tested  (not 
shown). 
The reactivities of HK-84 and HK-102 with the core mole- 
cules of LD were further examined using the immunoblot- 
ting technique. The heparitinase-treated LD was subjected to 
SDS-PAGE without reduction and subsequent immunoblot- 
ting. Both HK-84 and HK-102 stained the major two bands 
of 450,000 and  360,000 Mr (Fig.  2,  lanes  4  and  6).  The 
staining patterns were the same as the one with Coomassie 
Blue of the core molecules of LD (Fig. 2, lane 2) (Ledbetter 
et al.,  1987; Kato et al.,  1987). The results clearly indicate 
that mAbs of HK-84 and HK-102 recognize the core mole- 
cule of LD. When the reduced core molecule of LD was sub- 
jected to SDS-PAGE and subsequent immunoblotting, nei- 
ther HK-84 nor HK-102 stained the blotting membrane (not 
shown).  The complete loss of the reactivity with the mAb 
suggested that their epitopes may be on the core protein moi- 
ety of LD. 3 
We further assessed the epitope structures on the core mol- 
ecules of LD. LD was digested with V8 protease for 5 h at 
37°C.  The digests  were  subjected  to  SDS-PAGE  without 
heparitinase digestion and subsequent immunoblotting with 
HK-84 and HK-102.  Coomassie Blue staining  showed that 
the digestion produced major peptides  of 92,000,  80,000, 
46,000,  44,000, 29,000,  28,000,  15,000, and  13,000 Mr plus 
numerous minor peptides varying in size (Fig.  3, lane 1). 
Both HK-84 and HK-102 showed the reactivity with the frag- 
ments of 150,000,  120,000, 92,000,  80,000,  and 64,000 Mr 
released from LD (Fig. 3, lanes 2 and 3). Since the glycos- 
3.  This conclusion, however, should be considered with certain reserva- 
tions,  because  it  is  still  possible that  the  epitopes  were  conformation- 
dependent oligosaccharide-protein  interactions in which disulfide bonds 
were involved. Both epitopes appeared to be resistant to endoglycosidase F 
digestion under unreduced conditions (data not shown). However, the con- 
ditions used here were not yet confirmatory for the complete loss of the 
oligosaccharide. 
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with HK-84 (lanes 3 and 4) or HK-102 (lanes 5 and 6) before (lanes 
1, 3, and 5) and after (lanes 2,  4, and 6) heparitinase digestion. 
Lanes 1 and 2, stained with Coomassie Blue. Arrows indicate the 
positions of immunoreactive bands. Bands marked by asterisks in 
lane 2 were derived from a heparitinase preparation. 
Figure 3. SDS-PAGE of V8-digested LD (lane 1 ) and its immuno- 
blotting with HK-84 (lane 2) or HK-102 (lane 3). Lane 1, stained 
with Coomassie Blue. Arrows indicate the positions of immuno- 
reactive fragments from LD; from the top, 150,000, 120,000, 92,000, 
80,000, 64,000, 52,000, 46,000, 39,000, and  33,000 Mr.  Arrow- 
heads indicate the positions of standard proteins. 
aminoglycan-bound  fragments  derived  from  LD  by  the 
digestion  could hardly penetrate  into the  gel  (Kato et al., 
1987), 4 these antibody-reactive fragments would be derived 
from glycosaminoglycan-free core protein domains of LD. 
HK-84 could not react with the lower molecular mass frag- 
ments smaller than these (see the staining pattern with Coo- 
massie Blue,  Fig.  3,  lane 1).  However, HK-102  yet recog- 
nized four additional  smaller fragments of 52,000,  46,000, 
39,000,  and 33,000 Mr (Fig. 3, lane 3). The difference in the 
reactivity suggests that the epitope of HK-84 may have been 
on  the  peptides  released  from  the  64,000-Mr  fragments 
when it was converted into the smaller ones. 
Immunofluorescent Staining of Various Tissues 
with mAbs 
HK-102 was first used to examine the distribution of LD in 
various tissues from mouse. The extracellular matrix of the 
EHS tumor tissue from which the immunogen was prepared 
was stained intensely (Fig. 4 A). In normal mouse tissues, 
basement  membranes  surrounding  skeletal  muscle  fibers 
(endomysium) and  ones  surrounding  each cardiac  muscle 
cells were stained (Fig. 4, B and C, respectively). Alveolar 
and  bronchial  basement  membranes  in  lung  were  also 
stained (Fig. 4 D). Blood vessel endothelial basement mem- 
4. This was confirmed by the complete retention of the Alcian blue-positive 
fragments at the origin of the gel, which is probably due to the fact that the 
heparan sulfate chains of LD are extremely large in size (average 60,000 
Mr) (unpublished observations). 
branes  in  all  tissues  were intensely  stained.  Especially in 
brain, they were stained with characteristic features (Fig. 4 
E) and no significant difference was observed between cere- 
brum and cerebellum (not shown).  In kidney, all basement 
membranes of Bowman's capsule, glomerulus, and renal tu- 
bules, as far as could be detected, were stained strongly (Fig. 
5 A). When HK-84 was used to stain these tissues, the com- 
pletely same patterns were observed (not shown). These tis- 
sues were also stained with anti-mouse type IV collagen an- 
tibodies.  The patterns  were again completely the  same as 
those with HK-102  (Fig. 5 B; data on the tissues other than 
kidney were not shown).  Since type IV collagen has been 
well characterized as a constitutive component for all base- 
ment membranes (Timpl and Martin,  1982),  these  results 
suggest that the antigen of HK-84 or HK-102 is present in all 
basement membranes of all tissues. 
Immunodetection of  Heparan Sulfate Proteoglycan 
Core Molecules Isolated from Various Tissues 
We characterized molecules reactive with HK-84 and HK- 
102  in  the  tissues  in  which  basement  membranes  were 
stained with these monoclonal antibodies with expectation 
that the reactive molecules were the core molecule of LD. 
Direct application of the tissue extracts to SDS-PAGE dis- 
turbed the subsequent immunoblotting analysis, due to the 
large amounts of proteinous contaminants. Since the antigen 
of HK-84 and HK-102 is a negatively charged molecule, we 
have taken advantage of this nature.  Proteoglycan fractions 
were  prepared  from  various  tissues  by  DEAE-Sephacel 
The Journal of Cell Biology,  Volume 106,  1988  2206 Figure 4. Immunofluorescent staining of various mouse tissues with HK-102. (A) The EHS tumor; (B) skeletal muscle; (C) cardiac muscle; 
(D) lung;  (E) brain (cerebellum). Skeletal and cardiac muscle were  stained with nonimmunized rat serum  (G and H,  respectively). 
Nonspecific fluorescence was observed inside the cells but not on the basement membranes in the latter sample. Bar,  100 Bm. 
column  chromatography  as  described  in  Materials  and 
Methods.  The  fractions were then  treated with or without 
heparitinase and subjected to SDS-PAGE and subsequent im- 
munoblotting.  During  preparing  proteoglycans,  care  was 
taken  to  minimize  degradation  of core  molecules  as  de- 
scribed in Materials and Methods. 
In the proteoglycan preparations from the EHS tumor tis- 
sue 450,000-  and  360,000-Mr  core molecules of LD  were 
Kato et al.  mAbs to Basement Membrane Proteoglycan  2207 Figure 5. Immunofluorescent staining of mouse kidney with HK- 
102 (A) and anti-type IV collagen polyclonal antibodies (B). (C) 
Phase contrast micrograph of B. Note that HK-102  could react with 
all basement membranes that were recognized by anti-type IV col- 
lagen antibodies. Bar, 100 ~tm. 
detected (Fig.  6,  lane  1),  but an additional minor double 
band of 280,000 Mr was also detected. Since the fractions 
were prepared without CsC1 density gradient centrifugation 
in the present study,  the appearance of the minor doublet 
bands after heparitinase digestion was probably due to the 
difference in the preparation and revealed the presence of the 
LD which had a higher density than the typical LD in the 
EHS tumor tissue. 5 
In all samples without heparitinase digestion, smear and 
broad bands near the gel origin (Mr >  450,000)  were de- 
tected (Fig. 6, lanes 1-7) with weakly stained bands of  450,000 
Mr,  suggesting that some have less heparan sulfate chains 
and some are almost heparan sulfate free. When treated with 
heparitinase, large core molecules of 450,000 Mr, the same 
size as ones of LD, were commonly detected as major bands 
in all tissue samples  (Fig.  6,  lanes 2-7).  However, as ob- 
served with the EHS tumor sample, there were additional 
bands with tissue-specific variations. In skeletal muscle and 
cardiac muscle, a double band of ~  360,000 Mr was detected 
(Fig. 6, lanes 2 and 3). In lung, there was a single 360,000-Mr 
band (Fig. 6, lane 4). In kidney, two double bands of 360,000 
and 280,000 Mr were detected (Fig.  6, lane 6). In the glo- 
merulus preparation,  a  double band of 360,000 Mr and  a 
single band of 280,000 Mr were detected (Fig. 6, lane 7). It 
is noteworthy that any core molecules bands  smaller than 
280,000 Mr could not be detected in this preparation. In ad- 
dition, even when anti-BM-1  antibodies were used for the 
staining, we also obtained essentially the same immunoblot- 
ting pattern as those with the monoclonal antibodies (Fig. 7). 
Together with these results, heparan sulfate proteoglycans 
that are identical with LD are present in all basement mem- 
branes in all tissues examined. 
Discussion 
Our mAbs,  HK-84 and HK-102  recognized LD and mole- 
cules derived from LD, but did not have any reactivity with 
HD (Figs.  1 and 3). 
We have recently shown that some degradation products of 
LD  were  recovered in  the  HD  preparation  (Kato et  al., 
1987).  The  observations  that  polyclonal  antibodies  to 
purified HD showed the reactivity with LD (Dziadek et al., 
1985; Hassell et al., 1985) might be in part explained by this 
contamination.  If  so,  one  may  speculate  that  the  con- 
taminants in the HD preparation must be derived from the 
glycosaminoglycan-bound regions of LD in view of no reac- 
tivity of the monoclonal antibodies with HD together with 
the  epitope  locations  on  the  gycosaminoglycan-unbound 
regions of  core molecule of LD as discussed below. This pos- 
sibility is also supported by the previous observation that the 
glycosaminoglycan-bound derivatives from LD by V8 pro- 
tease digestion had a  density as high as  HD (Kato et al., 
1987). 
According to the assumption by Ledbetter et al.  (1987) 
5. CsCI density gradient centrifugation was used to divide the EHS tumor 
proteoglycan into twa forms: a high density form (0 >  1.60 g/ml) and a low 
density form (p <  1.45 g/ml) (Kato et al.,  1987).  When the proteoglycan 
fractions that have a density between the two were subjected to the size anal- 
ysis of the core molecule by heparitinase digestion, distinct double bands 
of the core molecule of 280,000 Mr were immunologically detected. 
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proteoglycan  fractions  from 
various  mouse  tissues  with 
HK  102. Samples from  the 
EHS tumor (lane 1), skeletal 
muscle (lane 2), cardiac mus- 
cle  (lane  3),  lung  (lane 4), 
brain  (lane 5),  kidney (lane 
6),  and glomerulus prepara- 
tion (lane 7) were subjected to 
SDS-gel  electrophoresis  be- 
fore (-) and after (+) hepa- 
ritinase  digestion and  subse- 
quently  to  immunoblotting. 
Arrows indicate the positions 
of immunoreactive bands. Ar- 
rowheads  indicate  the  posi- 
tions of standard proteins. The 
completely  identical  pattern 
was  obtained  when  HK-84 
was used for the immunostain- 
ing (see Fig. 7). 
Figure  7.  Inununoblotting of proteoglycan fractions from mouse 
glomeruli  with  anti-BM-1 polyclonal antibodies.  Samples were 
subjected to  SDS-PAGE before  (-)  and  after (+)  heparitinase 
digestion and then to immunoblotting. Arrows indicate the posi- 
tions of immunoreactive bands. Arrowheads indicate the positions 
of standard proteins. 
based on the kinetic study on the V8 protease digestion of 
LD,  the  200,000-Mr  peptide  that  lacks  heparan  sulfate 
chains is located at one end of the core protein of LD and 
the two 46,000- and 44,000-Mr peptides stable to the further 
digestion (probably by holding the structures with disulfide 
bonds) are contained within this polypeptide. Although strict 
comparison is  difficult between their assumption  and our 
findings in terms of the mobilities of the V8 protease diges- 
tion products on SDS-PAGE because of the differences in 
used experimental conditions,  their 46,000-Mr  peptide ap- 
peared  to  correspond  to  our  HK-102-positive  46,000-Mr 
fragment. If so, the epitope of HK-102 may be on this frag- 
ment, the one of HK-84 may be on the peptide close to this 
fragment, and the loss of the epitopes by reduction may be 
related to  the  disulfide-bonded holding  structure of these 
fragments. 
Both HK-84 and HK-102 showed positive immunofluores- 
cent staining to all basement membranes in tissues of skeletal 
muscle, cardiac muscle, lung, brain, and kidney (Figs. 4 and 
5). Moreover, by the immunoblotting technique using HK-84 
and HK-102, we observed in all proteoglycan fractions from 
these tissues  the  common existence of core molecules of 
heparan  sulfate proteoglycan which  were identical in  size 
with the ones of LD, although there were tissue-specific vari- 
ations in the relative amounts of core molecules of smaller 
size (Fig. 6). The result suggests that the positive fluorescent 
staining of the basement membranes in the tissues tested is 
due to the existence of LD, and therefore, this heparan sul- 
fate proteoglycan may be commonly present in  basement 
membranes. 
Heparan  sulfate  proteoglycans  that  have  a  450,000-Mr 
core molecule have been also found in amphibian muscle 
Kato et al. mAbs to Basement  Membrane Proteoglycan  2209 (Anderson and Fambrough,  1983),  L2 rat yolk sack tumor 
(Wewer  et  al.,  1985),  bovine  corneal  endothelial  cells 
(Lander  et  al.,  1985),  and  mouse  Reichert's  membranes 
(Paulsson et al., 1985). Moreover,  in immunoblottings using 
HK-84, HK-102,  or anti-BM-1 polyclonal antibodies, we re- 
cently  observed the occurrence of LD  in various cultured 
cells tested, mouse mammary epithelial cells, mouse mam- 
mary  mesenchymal  cells,  mouse  and  bovine  endothelial 
cells, mouse dermal fibroblasts,  baby hamster kidney (BHK) 
cells, and rat smooth muscle cells (Kato,  M., T. Okado, S. 
Suzuki, and K. Kamata, manuscript  in preparation).  There- 
fore, LD might be an essential component not only in tissues 
but also in various  types of cultured  cells. 
Many mechanisms for the observed tissue-specific varia- 
tions in size of the core molecules of LD could be operative. 
Ledbetter et al. (1985) observed that a precursor core mole- 
cule found within the EHS tumor cells was of a single poly- 
peptide of 400,000 Mr.  Therefore, the heterogeneity might 
be due to tissue-specific posttranslational  modification of the 
same precursor protein and might represent some functional 
differences in the various basement membranes. 
Heparan sulfate proteoglycan of murine glomerular base- 
ment membranes has been characterized  previously  (Edge 
and  Spiro,  1987;  Kanwer  et  al.,  1984;  Kobayashi  et  al., 
1983; Stow et al., 1985a). According to their reports, the in- 
tact size of the proteoglycan ranges from 130,000  to 200,000 
Mr and its  core molecule from  18,000  to  143,000  Mr.  We 
observed  the  existence  of LD  having  core  molecules  of 
450,000,  360,000,  and  280,000  Mr  not  only  in  im- 
munofluorescent staining  of kidney (Fig.  5) but also in im- 
munoblotting of the glomerular proteoglycan fraction with 
both  HK-84  and  HK-102  (Fig.  6).  Since  even  anti-BM-1 
polyclonal antibodies which were raised against the mixture 
of LD and HD (Hassell et al., 1980,  1985) did not stain any 
core molecules <280,000  Mr  (Fig.  7),  the  results  suggest 
the following alternative  possibility. In glomeruli, there may 
be other types of basement membrane heparan sulfate  pro- 
teoglycans that are not immunologically related to either LD 
or HD. Alternatively,  proteolysis that could occur during the 
extensive purification  procedure used to isolate glomerular 
basement membrane proteoglycans  might have  caused the 
differences in the sizes of the core molecules and the loss of 
antigenicity.  Additional experiments are needed to establish 
the relationship between glomerular and EHS tumor heparan 
sulfate  proteoglycans. 
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